Plasma Fibroblast Growth Factor 21 is Associated with Severity of Nonalcoholic Steatohepatitis in Patients with Obesity and Type 2 Diabetes.

CONCLUSIONS: Plasma FGF21 correlates with severity of steatohepatitis, in particular of fibrosis, in patients with NASH. Measurement of FGF21 may help identify patients at the highest risk of disease progression. PMID: 30848827 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/30848827?dopt=Abstract

Source: The Journal of Clinical Endocrinology and Metabolism - March 7, 2019 Category: Endocrinology Authors: Barb D, Bril F, Kalavalapalli S, Cusi K Tags: J Clin Endocrinol Metab Source Type: research